{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:20:19Z","timestamp":1776205219586,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Science Bulletin"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.scib.2024.02.039","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T17:27:44Z","timestamp":1709227664000},"page":"1286-1301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Adavosertib-encapsulated metal-organic frameworks for p53-mutated gallbladder cancer treatment via synthetic lethality"],"prefix":"10.1016","volume":"69","author":[{"given":"Shijie","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarun","family":"Juengpanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Win","family":"Topatana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiadong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukai","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yina","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlie","family":"Topatana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiasheng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiafei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jicheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.scib.2024.02.039_b0005","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly (ADP-ribose) polymerase","volume":"434","author":"Bryant","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.scib.2024.02.039_b0010","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.scib.2024.02.039_b0015","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13045-020-00956-5","article-title":"Advances in synthetic lethality for cancer therapy: Cellular mechanism and clinical translation","volume":"13","author":"Topatana","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.scib.2024.02.039_b0020","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrg.2017.47","article-title":"Synthetic lethality and cancer","volume":"18","author":"O'Neil","year":"2017","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.scib.2024.02.039_b0025","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41571-018-0055-6","article-title":"Synthetic lethal therapies for cancer: What\u2019s next after PARP inhibitors?","volume":"15","author":"Ashworth","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.scib.2024.02.039_b0030","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJMra1407390","article-title":"Applying synthetic lethality for the selective targeting of cancer","volume":"371","author":"McLornan","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.scib.2024.02.039_b0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.scib.2024.02.039_b0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","article-title":"Gallbladder cancer","volume":"8","author":"Roa","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.scib.2024.02.039_b0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.scib.2024.02.039_b0050","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1158\/2159-8290.CD-17-0245","article-title":"New horizons for precision medicine in biliary tract cancers","volume":"7","author":"Valle","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.scib.2024.02.039_b0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13045-021-01169-0","article-title":"Targeting mutant p53 for cancer therapy: Direct and indirect strategies","volume":"14","author":"Hu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.scib.2024.02.039_b0060","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2174\/157488410791498824","article-title":"Abrogation of the G2 checkpoint by inhibition of Wee-1 kinase results in sensitization of p53-deficient tumor cells to DNA-damaging agents","volume":"5","author":"Leijen","year":"2010","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.scib.2024.02.039_b0065","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1158\/1078-0432.CCR-17-0520","article-title":"Molecular pathways: Targeting the protein kinase Wee1 in cancer","volume":"23","author":"Geenen","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.scib.2024.02.039_b0070","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/emboj\/16.3.545","article-title":"Chk1 is a Wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation","volume":"16","author":"O'Connell","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.scib.2024.02.039_b0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","article-title":"State-of-the-art strategies for targeting the DNA damage response in cancer","volume":"16","author":"Pilie","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.scib.2024.02.039_b0080","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1158\/1541-7786.MCR-18-0860","article-title":"Multiple defects sensitize p53-deficient head and neck cancer cells to the Wee1 kinase inhibition","volume":"17","author":"Diab","year":"2019","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.scib.2024.02.039_b0085","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1158\/1078-0432.CCR-17-3796","article-title":"A phase I clinical trial of AZD1775 in combination with neoadjuvant weekly docetaxel and cisplatin before definitive therapy in head and neck squamous cell carcinoma","volume":"24","author":"Mendez","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.scib.2024.02.039_b0090","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1158\/2159-8290.CD-11-0320","article-title":"Forced mitotic entry of S-phase cells as a therapeutic strategy induced by inhibition of Wee1","volume":"2","author":"Aarts","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.scib.2024.02.039_b0095","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1158\/1078-0432.CCR-11-0650","article-title":"MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells","volume":"17","author":"Bridges","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.scib.2024.02.039_b0100","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1016\/S1470-2045(19)30537-6","article-title":"AZD1775 plus chemoradiotherapy for pancreatic cancer","volume":"20","author":"Burki","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.scib.2024.02.039_b0105","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1158\/1078-0432.CCR-20-3089","article-title":"Clinical efficacy and molecular response correlates of the wee1 inhibitor adavosertib combined with cisplatin in patients with metastatic triple-negative breast cancer","volume":"27","author":"Keenan","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.scib.2024.02.039_b0110","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1158\/1078-0432.CCR-17-1284","article-title":"Targeting AXL and mTOR pathway overcomes primary and acquired resistance to Wee1 inhibition in small-cell lung cancer","volume":"23","author":"Sen","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.scib.2024.02.039_b0115","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1200\/JCO.2016.67.5991","article-title":"Phase I study evaluating Wee1 inhibitor AZD1775 as monotherapy and in combination with gemcitabine, cisplatin, or carboplatin in patients with advanced solid tumors","volume":"34","author":"Leijen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.scib.2024.02.039_b0120","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1200\/JCO.2014.60.4009","article-title":"Phase I study of single-agent AZD1775 (MK-1775), a Wee1 kinase inhibitor, in patients with refractory solid tumors","volume":"33","author":"Do","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.scib.2024.02.039_b0125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41392-020-00358-6","article-title":"Development of synthetic lethality in cancer: Molecular and cellular classification","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.scib.2024.02.039_b0130","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1039\/D0CS01030H","article-title":"Stimuli-responsive metal-organic framework nanoparticles for controlled drug delivery and medical applications","volume":"50","author":"Zhou","year":"2021","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.scib.2024.02.039_b0135","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1021\/acsnano.1c09505","article-title":"Sequential ultrasound-triggered and hypoxia-sensitive nanoprodrug for cascade amplification of sonochemotherapy","volume":"16","author":"Zhuang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.scib.2024.02.039_b0140","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1039\/D1CS00056J","article-title":"The recent progress on metal-organic frameworks for phototherapy","volume":"50","author":"Zheng","year":"2021","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.scib.2024.02.039_b0145","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1021\/jacs.8b12705","article-title":"DNA-functionalized metal-organic framework nanoparticles for intracellular delivery of proteins","volume":"141","author":"Wang","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.scib.2024.02.039_b0150","article-title":"Bortezomib-encapsulated dual responsive copolymeric nanoparticles for gallbladder cancer targeted therapy","volume":"9","author":"Chen","year":"2022","journal-title":"Adv Sci"},{"key":"10.1016\/j.scib.2024.02.039_b0155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/acsnano.6b05910","article-title":"Overcoming tamoxifen resistance of human breast cancer by targeted gene silencing using multifunctional pRNA nanoparticles","volume":"11","author":"Zhang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.scib.2024.02.039_b0160","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201910084","article-title":"Fabrication of glyco-metal-organic frameworks for targeted interventional photodynamic\/chemotherapy for hepatocellular carcinoma through percutaneous transperitoneal puncture","volume":"30","author":"Hu","year":"2020","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.scib.2024.02.039_b0165","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1021\/jacs.6b00007","article-title":"Size-controlled synthesis of porphyrinic metal-organic framework and functionalization for targeted photodynamic therapy","volume":"138","author":"Park","year":"2016","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.scib.2024.02.039_b0170","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/s41467-022-28869-6","article-title":"Engineered assembly of water-dispersible nanocatalysts enables low-cost and green CO2 capture","volume":"13","author":"Alivand","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2024.02.039_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2022.122679","article-title":"Synthesis, characterization, and gas adsorption performance of an efficient hierarchical ZIF-11@ZIF-8 core\u2013shell metal\u2013organic framework (MOF)","volume":"307","author":"Hosseini","year":"2023","journal-title":"Sep Purif Technol"},{"key":"10.1016\/j.scib.2024.02.039_b0180","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202200872","article-title":"Injectable thermosensitive hydrogels for a sustained release of iron nanochelators","volume":"9","author":"Park","year":"2022","journal-title":"Adv Sci"},{"key":"10.1016\/j.scib.2024.02.039_b0185","article-title":"Responsive assembly of upconversion nanoparticles for pH-activated and near-infrared-triggered photodynamic therapy of deep tumors","volume":"30","author":"Li","year":"2018","journal-title":"Adv Mater"},{"key":"10.1016\/j.scib.2024.02.039_b0190","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1038\/s41467-023-41389-1","article-title":"Pre-activated nanoparticles with persistent luminescence for deep tumor photodynamic therapy in gallbladder cancer","volume":"14","author":"Juengpanich","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2024.02.039_b0195","doi-asserted-by":"crossref","first-page":"10734","DOI":"10.1021\/jacs.6b04875","article-title":"Intermolecular structural change for thermoswitchable polymeric photosensitizer","volume":"138","author":"Park","year":"2016","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.scib.2024.02.039_b0200","article-title":"Mitochondria-targeted nanosystem with reactive oxygen species-controlled release of CO to enhance photodynamic therapy of PCN-224 by sensitizing ferroptosis","volume":"19","author":"Yang","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.scib.2024.02.039_b0205","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.mattod.2022.12.004","article-title":"Ultrasound technology and biomaterials for precise drug therapy","volume":"63","author":"Zhao","year":"2023","journal-title":"Mater Today"},{"key":"10.1016\/j.scib.2024.02.039_b0210","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s12274-017-1719-8","article-title":"Ultrasound-triggered release of sinoporphyrin sodium from liposome-microbubble complexes and its enhanced sonodynamic toxicity in breast cancer","volume":"11","author":"Li","year":"2018","journal-title":"Nano Res"},{"key":"10.1016\/j.scib.2024.02.039_b0215","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ultras.2012.10.019","article-title":"The spectroscopy analyses of PpIX by ultrasound irradiation and its sonotoxicity in vitro","volume":"53","author":"Wang","year":"2013","journal-title":"Ultrasonics"},{"key":"10.1016\/j.scib.2024.02.039_b0220","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1002\/adma.201505869","article-title":"Light-activated hypoxia-responsive nanocarriers for enhanced anticancer therapy","volume":"28","author":"Qian","year":"2016","journal-title":"Adv Mater"},{"key":"10.1016\/j.scib.2024.02.039_b0225","doi-asserted-by":"crossref","first-page":"11302","DOI":"10.1021\/acs.chemrev.7b00161","article-title":"Generation and detection of reactive oxygen species in photocatalysis","volume":"117","author":"Nosaka","year":"2017","journal-title":"Chem Rev"},{"key":"10.1016\/j.scib.2024.02.039_b0230","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1021\/jacs.6b12074","article-title":"Singlet oxygen-engaged selective photo-oxidation over Pt nanocrystals\/porphyrinic MOF: The roles of photothermal effect and pt electronic state","volume":"139","author":"Chen","year":"2017","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.scib.2024.02.039_b0235","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41586-019-1102-x","article-title":"WRN helicase is a synthetic lethal target in microsatellite unstable cancers","volume":"568","author":"Chan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.scib.2024.02.039_b0240","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/s41467-021-21898-7","article-title":"Integrated cross-study datasets of genetic dependencies in cancer","volume":"12","author":"Pacini","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2024.02.039_b0245","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1476-4598-8-34","article-title":"Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor","volume":"8","author":"Mizuarai","year":"2009","journal-title":"Mol Cancer"},{"key":"10.1016\/j.scib.2024.02.039_b0250","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.trecan.2018.08.003","article-title":"Synthetic lethality and cancer-penetrance as the major barrier","volume":"4","author":"Ryan","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.scib.2024.02.039_b0255","doi-asserted-by":"crossref","first-page":"e2003214","DOI":"10.1002\/adma.202003214","article-title":"Recent advances in nanomaterial-assisted combinational sonodynamic cancer therapy","volume":"32","author":"Liang","year":"2020","journal-title":"Adv Mater"},{"key":"10.1016\/j.scib.2024.02.039_b0260","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1021\/acs.chemrev.1c00381","article-title":"Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy","volume":"121","author":"Pham","year":"2021","journal-title":"Chem Rev"},{"key":"10.1016\/j.scib.2024.02.039_b0265","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1021\/acsnano.2c10251","article-title":"Metal-organic frameworks (MOF)-assisted sonodynamic therapy in anticancer applications","volume":"17","author":"Yang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.scib.2024.02.039_b0270","doi-asserted-by":"crossref","first-page":"11227","DOI":"10.1039\/D1CS00403D","article-title":"Advanced biotechnology-assisted precise sonodynamic therapy","volume":"50","author":"Zhang","year":"2021","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.scib.2024.02.039_b0275","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1039\/C9CS00648F","article-title":"Multifunctional sonosensitizers in sonodynamic cancer therapy","volume":"49","author":"Son","year":"2020","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.scib.2024.02.039_b0280","doi-asserted-by":"crossref","first-page":"14212","DOI":"10.1002\/anie.201906823","article-title":"Ultrasound-activated sensitizers and applications","volume":"59","author":"Lin","year":"2020","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.scib.2024.02.039_b0285","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1021\/acs.nanolett.1c01220","article-title":"A robust oxygen-carrying hemoglobin-based natural sonosensitizer for sonodynamic cancer therapy","volume":"21","author":"Yuan","year":"2021","journal-title":"Nano Lett"},{"key":"10.1016\/j.scib.2024.02.039_b0290","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwaa221","article-title":"Multimodal channel cancer chemotherapy by 2D functional gadolinium metal-organic framework","volume":"8","author":"Xia","year":"2021","journal-title":"Natl Sci Rev"},{"key":"10.1016\/j.scib.2024.02.039_b0295","doi-asserted-by":"crossref","first-page":"39594","DOI":"10.1021\/acsami.9b14084","article-title":"Cell membrane-coated porphyrin metal-organic frameworks for cancer cell targeting and O2-evolving photodynamic therapy","volume":"11","author":"Zhang","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.scib.2024.02.039_b0300","doi-asserted-by":"crossref","first-page":"6835","DOI":"10.1038\/s41467-022-34462-8","article-title":"Near infrared-activatable biomimetic nanogels enabling deep tumor drug penetration inhibit orthotopic glioblastoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2024.02.039_b0305","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202204733","article-title":"An enzyme-engineered nonporous copper (I) coordination polymer nanoplatform for cuproptosis-based synergistic cancer therapy","volume":"34","author":"Xu","year":"2022","journal-title":"Adv Mater"},{"key":"10.1016\/j.scib.2024.02.039_b0310","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1021\/jacs.1c10168","article-title":"Near-infrared afterglow luminescence of chlorin nanoparticles for ultrasensitive in vivo imaging","volume":"144","author":"Chen","year":"2022","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.scib.2024.02.039_b0315","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.biomaterials.2015.04.049","article-title":"Balancing the effect of corona on therapeutic efficacy and macrophage uptake of lipid nanocapsules","volume":"61","author":"S\u00e1nchez-Moreno","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.scib.2024.02.039_b0320","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3390\/pharmaceutics14071325","article-title":"Doxorubicin-loaded core-shell UiO-66@SiO2 metal-organic frameworks for targeted cellular uptake and cancer treatment","volume":"14","author":"Trushina","year":"2022","journal-title":"Pharmaceutics"}],"container-title":["Science Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927324001415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927324001415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T20:06:28Z","timestamp":1714680388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095927324001415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2095927324001415"],"URL":"https:\/\/doi.org\/10.1016\/j.scib.2024.02.039","relation":{},"ISSN":["2095-9273"],"issn-type":[{"value":"2095-9273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adavosertib-encapsulated metal-organic frameworks for p53-mutated gallbladder cancer treatment via synthetic lethality","name":"articletitle","label":"Article Title"},{"value":"Science Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scib.2024.02.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Science China Press. Published by Elsevier B.V. and Science China Press.","name":"copyright","label":"Copyright"}]}}